When will Bumetanide Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Bumetanide Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Bumetanide Injection

Brand names: Bumetanide

Category: Cardiovascular

Limited 1Available 11

FDA status: Current · Last FDA update: Sep 18, 2026 · First posted: Jan 31, 2018 (in shortage 8 years 8 months) · 5 manufacturers, 12 listed presentations

As of Sep 18, 2026, the FDA lists Bumetanide Injection as currently in shortage. Of 12 manufacturer presentations, 1 Limited, 11 Available.

Ask your pharmacist: which of the 5 manufacturers below can they order right now, and whether a different strength or form of Bumetanide Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-04) NDC 25021-321-04	Sagent Pharmaceuticals	Limited	Estimated recovery: late September 2026
Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10) NDC 65219-572-10	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04) NDC 65219-570-04	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6008-10) NDC 0641-6008-10	Hikma Pharmaceuticals USA, Inc.	Available	Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6007-10) NDC 0641-6007-10	Hikma Pharmaceuticals USA, Inc.	Available	Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10) NDC 25021-321-10	Sagent Pharmaceuticals	Available	-
Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-101-07) NDC 72205-101-07	MSN Laboratories Private Limited	Available	-
Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-102-07) NDC 72205-102-07	MSN Laboratories Private Limited	Available	-
Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01) NDC 72205-101-01	MSN Laboratories Private Limited	Available	-
Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01) NDC 72205-102-01	MSN Laboratories Private Limited	Available	-
Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2) NDC 83301-0080-2	Mullan Pharmaceutical Inc.	Available	-
Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2) NDC 83301-0081-2	Mullan Pharmaceutical Inc.	Available	-

Related medications in shortage

Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Bumetanide Injection (FDA data as of Sep 18, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Bumetanide Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Bumetanide Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/bumetanide-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).